AdvisorNet Financial, Inc - AMPHASTAR PHARMACEUTICALS IN ownership

AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 213 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q1 2023. The put-call ratio across all filers is 0.26 and the average weighting 0.1%.

Quarter-by-quarter ownership
AdvisorNet Financial, Inc ownership history of AMPHASTAR PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$184
+222.8%
4
+300.0%
0.00%
Q2 2023$57
+50.0%
10.0%0.00%
Q1 2023$38
+35.7%
10.0%0.00%
Q4 2022$28
-100.0%
1
-100.0%
0.00%
-100.0%
Q1 2022$108,000
+54.3%
3,0000.0%0.01%
+75.0%
Q4 2021$70,000
+22.8%
3,0000.0%0.00%0.0%
Q3 2021$57,000
-5.0%
3,0000.0%0.00%0.0%
Q2 2021$60,0003,0000.00%
Other shareholders
AMPHASTAR PHARMACEUTICALS IN shareholders Q1 2023
NameSharesValueWeighting ↓
LAM GROUP, INC. 128,000$5,886,7205.78%
Beacon Harbor Wealth Advisors, Inc. 103,095$4,7411.58%
Capital Impact Advisors, LLC 15,304$703,8311.18%
Quantedge Capital Pte Ltd 36,389$1,673,5300.91%
Mesirow Institutional Investment Management, Inc. 183,805$8,453,1920.86%
Monashee Investment Management LLC 39,461$1,814,8110.76%
OBERWEIS ASSET MANAGEMENT INC/ 152,500$7,013,4750.74%
Granite Investment Partners, LLC 330,911$15,218,5970.64%
Portolan Capital Management 132,850$6,109,7720.57%
SHAKER INVESTMENTS LLC/OH 20,795$956,3620.53%
View complete list of AMPHASTAR PHARMACEUTICALS IN shareholders